SAN ANTONIO, Oct. 25 /PRNewswire/ -- BME (BioMedical Enterprises, Inc.) today announced that Andrew K. Palmer, MD, who has been serving as Medical Director, was elected to BME's Board of Directors.
"During this last year, Dr. Palmer has excelled in his leadership as Medical Director of BME by significantly enhancing BME's understanding of musculoskeletal problems, its surgeon relationships and corporate reputation. His informal advice to the BOD over this year has demonstrated his invaluable contributions to our corporate direction and governance and thus gained him unanimous support in taking this new position," stated Dr. Casey Fox, CEO.
Dr. Palmer has been a practicing upper extremity surgeon for over 30 years and is currently head of the Hand Division at the State University of New York's Department of Orthopedic Surgery in Syracuse. He is the author of numerous scientific publications and books and served as the 52nd president of the American Society for Surgery of the Hand (ASSH). Dr. Palmer will continue to serve as BME's Medical Director in addition to his role on BME's board of directors.
BioMedical Enterprises, Inc. (BME) is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. BME's focus on memory metal internal fixation implants is changing the shape of orthopaedic medicine. Its specialized history of musculoskeletal research services will continue to produce unique, state of the art orthopaedic products that provide better outcomes for patients and more convenience to surgeons. For more information visit http://www.bme-tx.com.
|SOURCE BioMedical Enterprises, Inc.|
Copyright©2007 PR Newswire.
All rights reserved